Scalable, parallel drug design: one researcher can run multiple campaigns simultaneously across targets and modalities * From research goal to lab ...
Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...
Shanghai Key Laboratory of New Drug Design, ECUST has the following research output in the current window (1 December 2024 - 30 November 2025) of the Nature Index. Click on Count to view a list of ...
Medra, an artificial intelligence startup focused on drug discovery, has raised $52 million in early-stage funding to try to integrate powerful large language models with physical systems that can ...
PM PT, Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical in muscle wasting and lean mass imbalance, aiming to ...
Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
A new class of cancer drug has been pushed to an almost unimaginable level of potency in the lab, with researchers reporting a 20,000‑fold jump in tumor‑killing power while aiming to spare healthy ...
Throughout the past few decades, antimicrobial resistance has been on the rise as a result of increased antibiotic use. Like an arms race played out on a tiny scale, pathogenic microbes develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results